The Sandiganbayan has denied the bid of former Department of Budget and Management (DBM) officials and Pharmally executives to junk the graft case filed against them over the alleged overpriced purchase of P4.4 billion worth of personal protective equipment and surgical face masks during the COVID-19 pandemic.
In a September 8 resolution, the anti-graft court denied separate motions filed by PS-DBM officials Allan Raul Catalan, Dickson Panti, Gerelyn Francisco Vergara, and Warren Liong, as well as Pharmally executives Linconn Ong and Mohit Dargani.
The court determined that the issue of conspiracy between PS-DBM officials and Pharmally executives is a matter of evidence that should be resolved during a full trial.
The Sandiganbayan stated that the elements of graft, including manifest partiality, evident bad faith, or gross inexcusable negligence, are alleged in the information and are sufficient in form and substance for the case to proceed.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.